Does cyclophosphamide combined with methylprednisolone affect the expression of leukocyte function associated antigen 1 in refractory rheumatoid arthritis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 4, 1997, Pages 285-288

  Łacki, Jan K ^a   Müller Ruchholtz, Wolfgang ^b   Mackiewicz, Stefan H ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Inst for Rheumatism Res and Prev   (Germany)

Author keywords

Cyclophosphamide; Leukocyte function association antigen 1; Methylprednisolone; Rheumatoid arthritis

Indexed keywords

CYCLOPHOSPHAMIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHYLPREDNISOLONE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; MALE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SYNOVIUM;

ADULT; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTE COUNT; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOCYTES; MALE; METHYLPREDNISOLONE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0030720324     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. BAST R. C., REINHERZ E. L. and MAVER C. (1983): Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes. Clin. Immunol. Immunopathol., 28, 101 - 107.
2. KAVANAUGH A. F., DAVIS L. S., NICHOLS L. A., NORRIS S. H., ROTHLEIN R., SCHARSCHMIDT L. A. and LIPSKY P. E. (1994): Treatment of refractory rheumatoid arthritis with monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum., 37, 992 - 999.
3. KOCH A. E., BURROWS J. C., HAINES G. K., CARLOS T. M., HARLAN J. M. and LEIBOVICH S. J. (1991): Immuno-localization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissue. Lab. Invest., 64, 313 - 320.
4. ŁACKI J. K., LESZCZYŃSKI and MACKIEWICZ S. H. (1996): Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis. The effect on lymphocytes. J. Invest. Allergol. Clin. Immunol., 6, 232 - 236.
5. STEVENSON H. C. and FAUCI 'A. S. (1980): Activation of human B lymphocytes. XII. Differential effect of in vitro cyclophosphamide on human lymphocyte sub-populations involved in B cell activity. Immunology, 39, 391 - 397.
6. THOMPSON A. W., NALESNIK M. A., RILO H. R., Woo J., CAROLL P. B. and VAN-THIEL D. H. (1993): ICAM-1 and E selectin expression in lesional biopsies of psoriasis patients responding to systemic FK506 therapy. Autoimmunity, 15, 215 - 223.
7. VAN-DINTHER-JANSSEN A. C., HORST E., KOOPMAN G., NEWMAN W., SCHEPER R. J., MEIJER C. J. and PALS S. T. (1991): The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J. Immunol., 147, 4207 - 4210.